Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P. - Tonix Pharmaceuticals (NASDAQ:TNXP)

CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates,

Related Keywords

United States ,Ben Shannon ,Zembrace Symtouch ,Jessica Morris ,Peter Vozzo ,Us National Institutes Of Health ,National Institute Of Allergy ,Upsher Smith Laboratories ,Tonix Pharmaceuticals ,Tonix Pharmaceuticals Holding Corp ,Trademark Office ,Exchange Commission ,Alliance Global Partners ,Alliance Global ,United States Patent ,New Drug Application ,Breakthrough Therapy ,Orphan Drug ,National Institute ,Infectious Diseases ,Project Nextgen ,Private Securities Litigation Reform Act ,Annual Report ,